chr9-72816152-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_138691.3(TMC1):āc.1705A>Gā(p.Thr569Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000191 in 1,613,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. T569T) has been classified as Likely benign.
Frequency
Consequence
NM_138691.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMC1 | NM_138691.3 | c.1705A>G | p.Thr569Ala | missense_variant | 19/24 | ENST00000297784.10 | |
TMC1 | XM_017014256.2 | c.1708A>G | p.Thr570Ala | missense_variant | 16/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMC1 | ENST00000297784.10 | c.1705A>G | p.Thr569Ala | missense_variant | 19/24 | 1 | NM_138691.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000219 AC: 55AN: 251340Hom.: 0 AF XY: 0.000272 AC XY: 37AN XY: 135826
GnomAD4 exome AF: 0.000194 AC: 283AN: 1461154Hom.: 0 Cov.: 30 AF XY: 0.000210 AC XY: 153AN XY: 726900
GnomAD4 genome AF: 0.000164 AC: 25AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Thr569Ala var iant in TMC1 has not been previously identified in individuals with hearing loss , but has been identified in 29/66722 European chromosomes by the Exome Aggregat ion Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs148971770). Comput ational prediction tools and conservation analysis suggest that the p.Thr569Ala variant may not impact the protein, though this information is not predictive en ough to rule out pathogenicity. In summary, while the clinical significance of t he p.Thr569Ala variant is uncertain, these data suggest that it is more likely t o be benign. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 11, 2022 | This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 569 of the TMC1 protein (p.Thr569Ala). This variant is present in population databases (rs148971770, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with TMC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 229317). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at